Dengue infections in travellers

Paediatrics and International Child Health

Volumn 32, Issue SUPP1, 2012, Pages 28-32

  Wilder Smith, Annelies ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Autochthonous spread; Dengue; GeoSentinel; Sentinel surveillance; Travellers

Indexed keywords

ARTICLE; CLINICAL FEATURE; DENGUE; DISEASE SEVERITY; HUMAN; INFECTION PREVENTION; INFECTION RISK; MALARIA; RISK FACTOR; SEASONAL VARIATION; SYMPTOM ASSESSMENT; TRAVEL; VIRUS TRANSMISSION; DISEASE TRANSMISSION; EMPORIATRICS; HEALTH SURVEY; INCIDENCE; METHODOLOGY; REVIEW; SOUTHEAST ASIA; TROPIC CLIMATE;

ASIA, SOUTHEASTERN; DENGUE; HUMANS; INCIDENCE; POPULATION SURVEILLANCE; RISK FACTORS; TRAVEL; TRAVEL MEDICINE; TROPICAL CLIMATE;

EID: 84867412384     PISSN: 20469047     EISSN: 20469055     Source Type: Journal    
DOI: 10.1179/2046904712Z.00000000050     Document Type: Article

References (41)

1. World Health Organization. Dengue and Dengue Haemorrhagic Fever; fact sheet 117, 2009 [cited 28 November 2011]. Available from: www.who.int/mediacentre/factsheets/fs117/en/.
2. World Health Organization. Infectious diseases of potential risk for travellers. In: International Travel and Health [cited 19 December 2011]. Available from: http://www.who.int/ith/chapters/en/index.html.
3. Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med. 2005;353:924-32.
4. World Tourism Organization, UNWTO. International tourists to hit 1.8 billion by 2030 [updated 11 October 2011, cited 28 November 2011]. Available from: http://media.unwto.org/en/pressrelease/2011-10-11/international-tourists-hit-18-billion-2030.
5. Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am. 2008;92:1377-90.
6. World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva, Switzerland: WHO, 2009.
7. Schwartz E, Weld LH, Wilder-Smith A, von Sonnenburg F, Keystone JS, Kain KC, et al. Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis. 2008;14:1081-8.
8. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354:119-30.
9. Cobelens FG, Groen J, Osterhaus AD, Leentvaar-Kuipers A, Wertheim-van Dillen PM, Kager PA. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health. 2002;7:331-8.
10. Potasman I, Srugo I, Schwartz E. Dengue seroconversion among Israeli travelers to tropical countries. Emerg Infect Dis. 1999;5:824-7.
11. Gibbons RV, Vaughn DW. Dengue: an escalating problem. Br Med J. 2002;324:1563-6.
12. Jelinek T. Trends in the epidemiology of dengue fever and their relevance for importation to Europe. Euro Surveill. 2009;14: 1-3.
13. Centers for Disease Control and Prevention (CDC). Travel-Associated Dengue Surveillance-United States, 2006-2008. Morbid Mortal Weekly Rep. 2010;59:715-19.
14. Sung V, O'Brien DP, Matchett E, Brown GV, Torresi J. Dengue fever in travelers returning from southeast Asia. J Travel Med. 2003;10:208-13.
15. Australian Government Department of Health and Ageing. National Notifiable Diseases Surveillance System. Number of notifications for all diseases by year, Australia, 1991 to 2010 and year-to-date notifications for 2011. [cited 25 November 2011]. Available from: http://www9.health.gov.au/cda/Source/Rpt_2_sel.cfm.
16. La Ruche G, Souares Y, Armengaud A, Peloux-Petiot F, Delaunay P, Despres P, et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 2010;15:19676.
17. Gjenero-Margan I, Aleraj B, Krajcar D, Lesnikar V, Klobucar A, Pem-Novosel I, et al. Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill. 2011;16:1-4.
18. Centers for Disease Control and Prevention. Locally acquired dengue-Key West, Florida, 2009-2010. Morbid Mortal Weekly Rep. 2010;59:577-81.
19. Russell RC, Currie BJ, Lindsay MD, Mackenzie JS, Ritchie SA, Whelan PI. Dengue and climate change in Australia: predictions for the future should incorporate knowledge from the past. Med J Aust. 2009;190:265-8.
20. Wagner D, de With K, Huzly D, Hufert F, Weidmann M, Breisinger S, et al. Nosocomial acquisition of dengue. Emerg Infect Dis. 2004;10:1872-3.
21. Chen LH, Wilson ME. Transmission of dengue virus without a mosquito vector: nosocomial mucocutaneous transmission and other routes of transmission. Clin Infect Dis. 2004;39:e56-60.
22. Wilder-Smith A, Chen LH, Massad E, Wilson ME. Threat of dengue to blood safety in dengue-endemic countries. Emerg Infect Dis. 2009;15:8-11.
23. Jelinek T, Muhlberger N, Harms G, Corachan M, Grobusch MP, Knobloch J, et al. Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis. 2002;35:1047-52.
24. Freedman D, Kozarskym P, Schwartz E. Thailand: out of season dengue outbreak in travellers to Koh Phangan. ProMed. Archive number: 20020426.4039 [updated 26 April 2002; cited 25 November 2011]. Available from: http://www.promedmail.org.
25. Massad E, Wilder-Smith A. Risk estimates of dengue in travelers to dengue endemic areas using mathematical models. J Travel Med. 2009;16:191-3.
26. McBride WJ, Mullner H, LaBrooy JT, Wronski I. The 1993 dengue 2 epidemic in Charters Towers, North Queensland: clinical features and public health impact. Epidemiol Infect. 1998;121:151-6.
27. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet. 2006;368:170-3.
28. Shepard DS, Suaya JA, Halstead SB, Nathan MB, Gubler DJ, Mahoney RT, et al. Cost-effectiveness of a pediatric dengue vaccine. Vaccine. 2004;22:1275-80.
29. World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd edn. Geneva, Switzerland: WHO, 1997.
30. Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjorup I, et al. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis. 2007;195:1089-96.
31. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38:172-80.
32. Whitehorn J, Simmons CP. The pathogenesis of dengue. Vaccine. 2011;29:7221-8.
33. Hagmann S, Neugebauer R, Schwartz E, Perret C, Castelli F, Barnett ED, et al. Illness in children after international travel: analysis from the GeoSentinel Surveillance Network. Pediatrics. 2010;125:e1072-80.
34. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborio SI, Mercado JC, et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg. 2005;73:1063-70.
35. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, Rothman AL, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet. 2007;369:1452-9.
36. Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6:118-24.
37. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8:S7-16.
38. Whitehorn J, Farrar J. Dengue. Br Med Bull. 2010;95:161-73.
39. Jelinek T. Dengue fever in international travelers. Clin Infect Dis. 2000;31:144-7.
40. Wilder-Smith A, Deen JL. Dengue vaccines for travelers. Expert Rev Vaccines. 2008;7:569-78.
41. Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J. From research to Phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. Vaccine. 2011;29:7229-41.